Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Market Cap $39.12M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
RLT | Ann: Change of Director's Interest Notice | 30/07/25 | 2 | 557 | |||
|
|||||||
RLT | Ann: Change of Director's Interest Notice | 30/07/25 | 0 | 218 | |||
|
|||||||
RLT | ASP Isotopes to possibly acquire Renergen | 28/07/25 | 234 | 84K | |||
|
|||||||
RLT | Ann: Results of Meeting | 28/07/25 | 0 | 321 | |||
|
|||||||
RLT | Renergen General Discussion | 27/07/25 | 4.9K | 1.5M | |||
|
|||||||
RLT | Ann: Competition Authorities Approval of the ASPI offer | 24/07/25 | 0 | 308 | |||
|
|||||||
RLT | Ann: Results of Meeting | 11/07/25 | 0 | 387 | |||
|
|||||||
RLT | Ann: Subsidiary Shareholder Matter | 10/07/25 | 2 | 846 | |||
|
See All Discussions
Timeline
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
View More |